Owner Aventis Pharma S.A.

Inventors Itier, Jean-Michel; Ret, Gwenaelle; Stutzmann, Jean-Marie; Multon, MarieChristine; Wahl, Florence

Agent Davies Collison Cave

Pub. Number AU-B-2001284112

PCT Pub. Number WO02/12901

Priority 00 10539 10.08.00 FR

Filing date 7 August 2001

Wipo publication date 18 February 2002

Acceptance publication date 22 March 2007

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/04 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Determining presence or kind of micro-organism

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids